Modulation of T-cell receptor signal transduction by herpesvirus signaling adaptor protein

被引:8
|
作者
Lee, SH
Chung, YH
Cho, NH
Gwack, Y
Feng, PH
Jung, JU
机构
[1] Harvard Univ, Sch Med, New England Reg Primate Res Ctr, Tumor Virol Div, Southborough, MA 01772 USA
[2] Harvard Univ, Sch Med, Dept Microbiol & Mol Genet, Southborough, MA 01772 USA
[3] Pusan Natl Univ, Sch Nanosci & Technol, Pusan, South Korea
关键词
D O I
10.1128/MCB.24.12.5369-5382.2004
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Because of its central regulatory role, T-cell receptor (TCR) signal transduction is a common target of viruses. We report here the identification of a small signaling protein, ORF5, of the T-lymphotropic tumor virus herpesvirus saimiri (HVS). ORF5 is predicted to contain 89 to 91 amino acids with an amino-terminal myristoylation site and six SH2 binding motifs, showing structural similarity to cellular ILAT (linker for activation of T cells). Sequence analysis showed that, despite extensive sequence variation, the myristoylation site and SH2 binding motifs were completely conserved among 13 different ORF5 isolates. Upon TCR stimulation, ORF5 was efficiently tyrosine phosphorylated and subsequently interacted with cellular SH2-containing signaling proteins Lck, Fyn, SLP-76, and p85 through its tyrosine residues. ORF5 expression resulted in the marked augmentation of TCR signal transduction activity, evidenced by increased cellular tyrosine phosphorylation, intracellular calcium mobilization, CD69 surface expression, interleukin-2 production, and activation of the NF-AT, NF-kappaB, and AP-1 transcription factors. Despite its structural similarity to cellular LAT, however, ORF5 could only partially substitute for LAT function in TCR signal transduction. These results demonstrate that HVS utilizes a novel signaling protein, ORF5, to activate TCR signal transduction. This activation probably facilitates viral gene expression and, thereby, persistent infection.
引用
收藏
页码:5369 / 5382
页数:14
相关论文
共 50 条
  • [21] Dual modulation of the T-cell receptor-activated signal transduction pathway by morphine in human T lymphocytes
    Mizota, Toshiyuki
    Tsujikawa, Hiroshi
    Shoda, Takehiro
    Fukuda, Kazuhiko
    JOURNAL OF ANESTHESIA, 2013, 27 (01) : 80 - 87
  • [22] T-cell signal transduction and the role of protein kinase C
    S. E. Wilkinson
    J. S. Nixon
    Cellular and Molecular Life Sciences CMLS, 1998, 54 : 1122 - 1144
  • [23] T-cell signal transduction and the role of protein kinase C
    Wilkinson, SE
    Nixon, JS
    CELLULAR AND MOLECULAR LIFE SCIENCES, 1998, 54 (10) : 1122 - 1144
  • [24] NEW INSIGHTS INTO T-CELL ANTIGEN RECEPTOR STRUCTURE AND SIGNAL TRANSDUCTION
    CHAN, AC
    IRVING, BA
    WEISS, A
    CURRENT OPINION IN IMMUNOLOGY, 1992, 4 (03) : 246 - 251
  • [25] PHOSPHORYLATION OF THE T-CELL ANTIGEN RECEPTOR - MULTIPLE SIGNAL TRANSDUCTION PATHWAYS
    KLAUSNER, RD
    PATEL, MD
    OSHEA, JJ
    SAMELSON, LE
    JOURNAL OF CELLULAR PHYSIOLOGY, 1987, : 49 - 51
  • [26] FUNCTION OF A HETEROLOGOUS MUSCARINIC RECEPTOR IN T-CELL ANTIGEN RECEPTOR SIGNAL TRANSDUCTION MUTANTS
    GOLDSMITH, MA
    DESAI, DM
    SCHULTZ, T
    WEISS, A
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1989, 264 (29) : 17190 - 17197
  • [27] T-CELL ANTIGEN RECEPTOR SIGNAL TRANSDUCTION - A TALE OF TAILS AND CYTOPLASMIC PROTEIN-TYROSINE KINASES
    WEISS, A
    CELL, 1993, 73 (02) : 209 - 212
  • [28] Phase separation of signaling molecules promotes T cell receptor signal transduction
    Su, Xiaolei
    Ditlev, Jonathon A.
    Hui, Enfu
    Xing, Wenmin
    Banjade, Sudeep
    Okrut, Julia
    King, David S.
    Taunton, Jack
    Rosen, Michael K.
    Vale, Ronald D.
    SCIENCE, 2016, 352 (6285) : 595 - 599
  • [29] Phase separation of signaling molecules promotes T cell receptor signal transduction
    Su, Xiaolei
    Ditlev, Jon
    Hui, Enfu
    Banjade, Sudeep
    Okrut, Julia
    Taunton, Jack
    Rosen, Mike
    Vale, Ron
    CANCER IMMUNOLOGY RESEARCH, 2016, 4 (01)
  • [30] T-CELL IMMUNODEFICIENCY WITH A DEFECTIVE SIGNAL TRANSDUCTION
    CHATILA, TA
    TERHORST, C
    GEHA, RS
    CLINICAL RESEARCH, 1987, 35 (03): : A613 - A613